{"id":"W2551016480","doi":"10.1182/blood.v110.11.3420.3420","title":"Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Dosing; Internal medicine; Clinical endpoint; Randomized controlled trial; Neutropenia; Gastroenterology; Lymphoma; Randomization; Urology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002504353,0.0002460114,0.0004891856,0.0001512324,0.00006346375,0.00001652199,0.0001952725,0.0001969861,0.0001487518],"category_scores_gemma":[0.00009614346,0.0002002774,0.0002375445,0.000320543,0.0001079161,0.000003698926,0.0001269252,0.00007994695,0.000006564658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005187314,"about_ca_system_score_gemma":0.0003096555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005977241,"about_ca_topic_score_gemma":0.0006969454,"domain_scores_codex":[0.9984319,0.00008616128,0.0005223731,0.0004772713,0.0001517884,0.0003305027],"domain_scores_gemma":[0.9989566,0.0000922988,0.0002460457,0.000416728,0.0001495974,0.0001387382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3053442,0.05279218,0.005165157,0.0001584565,0.01385262,0.0005757538,0.0008277937,0.001199189,0.5456609,0.0001685007,0.001147598,0.07310764],"study_design_scores_gemma":[0.2082667,0.05323093,0.002420834,0.00002898227,0.005131318,0.00002989619,0.0003194521,0.0006532387,0.6605498,0.0000156984,0.06873454,0.0006186633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762226,0.0003569058,0.0009887597,0.00004194952,0.0001390687,0.02050682,0.0001147247,0.00001430797,0.001614849],"genre_scores_gemma":[0.9838598,0.0001433339,0.001941571,0.0001579986,0.0004985739,0.01272094,0.0002048387,0.00003277859,0.000440161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1148888,"threshold_uncertainty_score":0.8167076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02369911680455644,"score_gpt":0.3458533971926748,"score_spread":0.3221542803881183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}